AB Science S.A. (OTCMKTS:ABSCF) Short Interest Update

AB Science S.A. (OTCMKTS:ABSCF) saw a significant decrease in short interest in April. As of April 15th, there was short interest totalling 400 shares, a decrease of 95.0% from the March 31st total of 8,000 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ? days.

AB Science Price Performance

ABSCF stock opened at $2.70 on Friday. AB Science has a 1-year low of $2.55 and a 1-year high of $3.84. The stock’s fifty day simple moving average is $3.17 and its two-hundred day simple moving average is $4.01.

AB Science Company Profile

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.